Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +45.40%
#3 Pons Pons +21.76%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +16.03%
#6 Collect on Fanable Collect on Fanable +14.73%
#7 Cysic Cysic +13.73%
#8 Ontology Gas Ontology Gas +13.53%
#9 o1.exchange o1.exchange +13.31%
#10 OpenGradient OpenGradient +11.75%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rangering i aksjer #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aksjekurs
$0.2219522
Sist synkronisert: 2025-09-11
Markedsverdi
$1.10B
Endring (1 dag)
0.04%
Endring (1 år)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Kategori

Financial Services
P/S-forhold for Hubei Biocause Pharmaceutical Co., Ltd. (000627)
P/S-forhold per August 2026 TTM: 0.16
Ifølge Hubei Biocause Pharmaceutical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0.16. Ved slutten av 2022 hadde selskapet et P/S-forhold på 0.31.
P/S-historikk for Hubei Biocause Pharmaceutical Co., Ltd. fra 2000 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 0.16 -44.32%
2023 0.28 -9.91%
2022 0.31 -4.58%
2021 0.33 -40.28%
2020 0.55 -20.19%
2019 0.69 -22.30%
2018 0.89 32.65%
2017 0.67 -63.11%
2016 1.82 -93.34%
2015 27.32 249.63%
2014 7.81 114.32%
2013 3.65 -23.01%
2012 4.73 38.93%
2011 3.41 -36.39%
2010 5.36 1.98%
2009 5.25 133.47%
2008 2.25 -70.72%
2007 7.69 165.80%
2006 2.89 172.12%
2005 1.06 -63.15%
2004 2.88 -20.44%
2003 3.62 -72.89%
2002 13.37 64.55%
2001 8.12 4.25%
2000 7.79 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
2.00 1,183.26%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
3.05 1,856.45%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
- -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
- -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
- -
US